Elizabeth O’Day

2.4k total citations
28 papers, 1.8k citations indexed

About

Elizabeth O’Day is a scholar working on Molecular Biology, Cancer Research and Clinical Biochemistry. According to data from OpenAlex, Elizabeth O’Day has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Clinical Biochemistry. Recurrent topics in Elizabeth O’Day's work include Metabolomics and Mass Spectrometry Studies (5 papers), Metabolism and Genetic Disorders (4 papers) and RNA modifications and cancer (4 papers). Elizabeth O’Day is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (5 papers), Metabolism and Genetic Disorders (4 papers) and RNA modifications and cancer (4 papers). Elizabeth O’Day collaborates with scholars based in United States, Belgium and United Kingdom. Elizabeth O’Day's co-authors include Ashish Lal, Judy Lieberman, Gerhard Wagner, Oliver Hofmann, Francisco Navarro, Mohamed M. Emara, Nan Yan, Pavel Ivanov, Paul Anderson and Dipanjan Chowdhury and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Elizabeth O’Day

27 papers receiving 1.8k citations

Peers

Countries citing papers authored by Elizabeth O’Day

Since Specialization

Citations

This map shows the geographic impact of Elizabeth O’Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth O’Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth O’Day more than expected).

Fields of papers citing papers by Elizabeth O’Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth O’Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth O’Day. The network helps show where Elizabeth O’Day may publish in the future.

Co-authorship network of co-authors of Elizabeth O’Day

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth O’Day. A scholar is included among the top collaborators of Elizabeth O’Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth O’Day. Elizabeth O’Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Urinary metabolite signatures to detect and differentiate graft injury in kidney transplant patients 2025 ·iScience ·Chen Dong, Alessia Trimigno, (unknown), (unknown), Elizabeth O’Day, Dirk Kuypers	0
2	Perspective: metabolomics has the potential to change the landscape of kidney transplantation diagnostics 2024 ·Biomarkers in Medicine ·Dirk Kuypers, Jurre J. Kamphorst, Henriëtte de Loor, Elizabeth O’Day	1
3	Metabolic Choreography of Energy Substrates During DCD Heart Perfusion 2024 ·Transplantation Direct ·Alessia Trimigno, (unknown), William A. Michaud, (unknown), (unknown), David A. D’Alessandro, Greg Lewis, (unknown), (unknown), (unknown), (unknown), (unknown), Shannon N. Tessier, Selena S. Li, Elizabeth O’Day, Asishana A. Osho, S. Alireza Rabi	1
4	Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients 2022 ·Metabolites ·Dong Chen, Chandrashekhar Honrao, Leonardo O. Rodrigues, (unknown), (unknown), Matthew Surface, Roy N. Alcalay, Elizabeth O’Day	9
5	Metabolite Biomarkers of Response (BoRs): Towards a fingerprint for the evolution of metastatic breast cancer 2021 ·Progress in Biophysics and Molecular Biology ·(unknown), Chen Dong, Elizabeth O’Day	1
6	Abstract P4-10-25: Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer 2020 ·Cancer Research ·Elizabeth O’Day, Kim Leitzel, Suhail M. Ali, Bo Zhang, Dong Chen, Haiwei Gu, (unknown), Joseph J. Drabick, (unknown), Monali Vasekar, (unknown), (unknown), (unknown), (unknown), Harry Menon, (unknown), Walter P. Carney, W. Koestler, Allan Lipton	7
7	Cytidine monophosphate <em>N</em>-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells 2018 ·OncoTargets and Therapy ·Elizabeth O’Day, (unknown), Collin Hill, Joan Chen, Gerhard Wagner	14
8	Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health 2018 ·Biotechnology Journal ·Elizabeth O’Day, Leticia Hosta‐Rigau, Diego A. Oyarzún, Hideyuki Okano, Vı́ctor de Lorenzo, (unknown), Habiba Alsafar, Cong Cao, Guo‐Qiang Chen, Weizhi Ji, (unknown), Mostafa Ronaghi, Karen Yeung, Feng Zhang, Sang Yup Lee	4
9	An RNA-binding Protein, Lin28, Recognizes and Remodels G-quartets in the MicroRNAs (miRNAs) and mRNAs It Regulates 2015 ·Journal of Biological Chemistry ·Elizabeth O’Day, Minh T. N. Le, Shunsuke Imai, Shen Mynn Tan, Rory Kirchner, Haribabu Arthanari, Oliver Hofmann, Gerhard Wagner, Judy Lieberman	29
10	G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments 2014 ·Proceedings of the National Academy of Sciences ·Pavel Ivanov, Elizabeth O’Day, Mohamed M. Emara, Gerhard Wagner, Judy Lieberman, Paul Anderson	269
11	Nanobodies Raised against Monomeric α-Synuclein Distinguish between Fibrils at Different Maturation Stages 2013 ·Journal of Molecular Biology ·Tim Guilliams, Farah El-Turk, Alexander K. Buell, Elizabeth O’Day, Francesco A. Aprile, Elin K. Esbjörner, Michele Vendruscolo, Nunilo Cremades, Els Pardon, Lode Wyns, Mark E. Welland, Jan Steyaert, John Christodoulou, Christopher M. Dobson, Erwin De Genst	89
12	Capture of MicroRNA–Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor Signaling 2011 ·PLoS Genetics ·Ashish Lal, Marshall P. Thomas, Gabriel Altschuler, Francisco Navarro, Elizabeth O’Day, Xiao Ling Li, Carla P. Concepcion, Yoon-Chi Han, Jérôme Thiery, (unknown), Aaron J. Deutsch, Oliver Hofmann, Andrea Ventura, (unknown), Judy Lieberman	199
13	HIV DNA is heavily uracilated, which protects it from autointegration 2011 ·Proceedings of the National Academy of Sciences ·Nan Yan, Elizabeth O’Day, Lee Adam Wheeler, Alan Engelman, Judy Lieberman	54
14	MicroRNAs and their target gene networks in breast cancer 2010 ·Breast Cancer Research ·Elizabeth O’Day, Ashish Lal	359
15	Structure and Properties of a Complex of α-Synuclein and a Single-Domain Camelid Antibody 2010 ·Journal of Molecular Biology ·Erwin J. De Genst, Tim Guilliams, (unknown), Elizabeth O’Day, Christopher A. Waudby, Sarah Meehan, Mireille Dumoulin, Shang‐Te Danny Hsu, Nunilo Cremades, Koen H. G. Verschueren, Els Pardon, Lode Wyns, Jan Steyaert, John Christodoulou, Christopher M. Dobson	147
16	miR-24 Inhibits Cell Proliferation by Targeting E2F2, MYC, and Other Cell-Cycle Genes via Binding to “Seedless” 3′UTR MicroRNA Recognition Elements 2009 ·Molecular Cell ·Ashish Lal, Francisco Navarro, Christopher A. Maher, Laura Maliszewski, Nan Yan, Elizabeth O’Day, Dipanjan Chowdhury, Derek M. Dykxhoorn, Perry Tsai, Oliver Hofmann, Kevin G. Becker, Myriam Gorospe, (unknown), Judy Lieberman	483
17	1H, 13C and 15N assignments of a camelid nanobody directed against human α-synuclein 2009 ·Biomolecular NMR Assignments ·(unknown), Elizabeth O’Day, Erwin De Genst, Els Pardon, Lode Wyns, Mireille Dumoulin, Christopher M. Dobson, John Christodoulou, Shang‐Te Danny Hsu	31
18	Teaching: A Reflective Process 2009 ·(unknown), Elizabeth O’Day	2
19	Time Evolution of the Quaternary Structure of Escherichia coli Aspartate Transcarbamoylase upon Reaction with the Natural Substrates and a Slow, Tight-Binding Inhibitor 2008 ·Journal of Molecular Biology ·(unknown), (unknown), Hiro Tsuruta, (unknown), Elizabeth O’Day, Evan R. Kantrowitz	12
20	Use of L‐asparagine and N‐phosphonacetyl‐L‐asparagine to investigate the linkage of catalysis and homotropic cooperativity in E. coli aspartate transcarbomoylase 2007 ·Proteins Structure Function and Bioinformatics ·James Cardia, Joby Eldo, (unknown), Elizabeth O’Day, Hiro Tsuruta, (unknown), Evan R. Kantrowitz	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact